"Europe Against Cancer" publications relative to our FusionQuant® products:
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Leukemia. 2003 Dec;17(12):2318-57
Authors: Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cavé H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, González M, Viehmann S, Malec M, Saglio G, van Dongen JJ.
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Leukemia. 2003 Dec;17(12):2474-86
Authors: Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J.
Others:
Identification of TCL1 as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas.
Int J Oncol. 26(1):151-157, 2005.
Authors: Ramuz O, Bouabdallah R, Devilard E, Borie N, Groulet-Martinec A, Bardou VJ, Brousset P, Bertucci D, Birg F, Birnbaum D, Xerri L.
Identification of new classes among acute myelogenous Leukemia with normal karyotype using gene expression profiling.
Oncogene. 23(58):9381-9391, 2004.
Authors: Vey N, Mozziconacci MJ, Groulet A, Debono S, Finetti P, Carbuccia N, Beillart E, Devilard E, Arnoulet C, Coso D, Sainty D, Xerri L, Stoppa AM, Lafage-Pochitaloff M, Nguyen C, Houlgatte R, Blaise D, Maraninchi D, Birg F, Birnbaum D, Bertucci F.
A diagnostic biochip for the comprehensive analysis of MLL translocations in acute Leukemia.
Leukemia. 18(9):1522-1530, 2004.
Authors: Maroc N, Morel A, Beillard E, Lamy de la Chapelle A, Fund X, Mozziconacci MJ, Dupond M, Cayuela JM, Gabert J, Koki A, Fert V, Hermitte F.
Gene expression profiling defines molecular subtypes of classical Hodgkin’s disease.
Oncogene. 21:3095-3102, 2002.
Authors: Devilard E, Bertucci F, Bouabdallah R, Trempat P, Giaconia A, Loriod B, Nguyen C, Birnbaum D, Birg F, Houlgatte R, Xerri L.
